Cipla Invests in iCaltech Innovations to Boost Respiratory Portfolio

Cipla will acquire a 20% stake in iCaltech, through an investment of approximately INR 5 Cr in optionally convertible preference shares and one equity share.

Pharma major Cipla has signed definitive agreements for investment in optionally convertible preference shares of iCaltech Innovations, a Bengaluru-based medical device company.

With a focus on respiratory care, iCaltech is engaged in the design, development, and commercialization of diagnostic medical equipment and apparatus, aligning with Cipla’s strategy to strengthen its presence in the respiratory care space.

Cipla will acquire a 20% stake in iCaltech, through an investment of approximately INR 5 Cr in optionally convertible preference shares and one equity share.

Achin Gupta, Global COO, Cipla, said, “Our decision to invest in iCaltech reflects Cipla's commitment to advancing respiratory diagnostics. As lung leaders with the aim to reduce the existing gap in the current ecosystem, our strategic funding will enable iCaltech to further expand and develop innovative devices.”

Further, Cipla commented that the deal would enable it to partner with iCaltech in developing integrated healthcare solutions by leveraging synergies between pharmaceuticals and medical device technologies.

Stay tuned for more such updates on Digital Health News